Further evidence supporting our results is the potential association observed by Liu and collaborators [41] between miR-339 downregulation and increased expression of tumor PD-L1, resulting in an attenuated antitumor immune response in RCC patients. The gene discussed is CD274; the disease is renal cell carcinoma.